Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The integrase allosteric pocket in HIV-1 is a specific site on the viral integrase (IN) enzyme that serves as a binding region for allosteric inhibitors. This pocket overlaps with the binding site of the host cellular cofactor LEDGF/p75, which normally tethers integrase to chromatin and facilitates integration of viral DNA into the host genome. ALLINIs bind to this site, inducing aberrant multimerization of IN, disrupting normal assembly with viral DNA, and perturbing maturation of new virions. This results in defective virus particles unable to complete reverse transcription or integrate their genome. Targeting this site offers an alternative therapeutic strategy against HIV, especially for resistant strains.
Induces aberrant integrase multimerization, disrupts virion maturation, inhibits viral integration.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrase Allosteric Pocket (HIV).